Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation

Clinical trial NCT04140409 · TERMINATED

Trial details

NCT number: NCT04140409
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Neuroendocrine Tumors Carcinoid Syndrome

Start date: 2016-02-02
Primary completion: 2019-06-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.